Asthma and COPD Drugs Market is expected to reach US$ 82.2 Billion by 2036, driven by Advancements in Drug Discovery and ...

Access the Akari CEO Corner hereTAMPA, Fla. and LONDON, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: ...

Peer-reviewed publication in “The Oncologist” is now available onlineInvestigational same-day dosing of Rolvedon demonstrated a clinical response and adverse event profile similar to next-day ...

HOUSTON, JANUARY 9, 2026 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...

Supporting patients with acute respiratory distress syndrome (ARDS), remains a critical challenge in intensive care units ...

Stanford researchers have developed an AI that can predict future disease risk using data from just one night of sleep. The ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

Our writers kept up with the latest football news and comment going into FA Cup third-round weekend ...

New research suggests vesicles from the Salvia miltiorrhiza plant may treat acute lung injury (ALI) by reducing inflammation ...

These two dividend stocks are focused on steady, repeatable payouts with yields up to 12.5%. Here's what income investors ...